Cartesian Therapeutics Inc.

12/03/2024 | Press release | Distributed by Public on 12/03/2024 05:49

Cartesian Therapeutics Announces Positive Updated Results from Phase 2b Trial of Descartes-08 in Participants with Myasthenia Gravis and Outlines Design of Planned Phase 3 Trial

Read this content
Click here to read the original version at the source's official website. The text of this article is not available at the moment.